Global Information
회사소개 | 문의 | 비교리스트

아티파메졸 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2020-2030년)

Atipamezole Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

리서치사 Transparency Market Research
발행일 2020년 06월 상품 코드 953639
페이지 정보 영문 190 Pages
가격
US $ 5,795 ₩ 6,391,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 9,700,000 PDF (Multi-user License)
US $ 11,795 ₩ 13,009,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


아티파메졸 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2020-2030년) Atipamezole Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
발행일 : 2020년 06월 페이지 정보 : 영문 190 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 아티파메졸 시장에 대해 분석했으며, 시장의 기본 구조와 주요 영향요인, 시장 규모 동향 전망(과거 2년간·향후 11년간), 용도별·투여 경로별·동물 종류별·유통 채널별 및 지역별 상세 동향, 경쟁 상황(시장 점유율 구조), 주요 기업 개요 등을 조사했습니다.

목차

제1장 서문

제2장 가정과 분석 방법

제3장 주요 요약 : 세계의 아티파메졸 시장

제4장 시장 개요

  • 서론
    • 용도/정의
  • 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 세계의 아티파메졸 시장 분석과 예측(2018-2030년)

제5장 주요 인사이트

  • 규제 시나리오
  • 동물 사육두수 : 국가별/지역별
  • 수의 의료 개요

제6장 세계의 아티파메졸 시장 분석과 예측 : 용도별

  • 서론과 정의
  • 주요 분석 결과/동향
  • 아티파메졸 시장 규모 : 용도별(금액 기준, 2018-2030년)
    • 진정제
    • 항독성(적응외 사용)
  • 시장 매력 : 용도별

제7장 세계의 아티파메졸 시장 분석과 예측 : 투여 경로별

  • 서론과 정의
  • 주요 분석 결과/동향
  • 아티파메졸 시장 규모 : 투여 경로별(금액 기준, 2018-2030년)
    • 근육내 주사
    • 정맥내 주사
    • 기타
  • 시장 매력 : 투여 경로별

제8장 세계의 아티파메졸 시장 분석과 예측 : 동물 종류별

  • 서론과 정의
  • 주요 분석 결과/동향
  • 아티파메졸 시장 규모 : 동물 종류별(금액 기준, 2018-2030년)
    • 고양이
    • 기타
  • 시장 매력 : 동물 종류별

제9장 세계의 아티파메졸 시장 분석과 예측 : 유통 채널별

  • 서론과 정의
  • 주요 분석 결과/동향
  • 아티파메졸 시장 규모 : 유통 채널별(금액 기준, 2018-2030년)
    • 수의 병원
    • 소매 약국
    • 온라인 약국
  • 시장 매력 : 유통 채널별

제10장 세계의 아티파메졸 시장 분석과 예측 : 지역별

  • 분석 포인트
  • 아티파메졸 시장 규모 : 지역별(금액 기준, 2018-2030년)
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력 : 국가별/지역별

제11장 북미의 아티파메졸 시장 분석과 예측

  • 서론
    • 주요 조사 결과
  • 시장 규모 : 용도별(금액 기준, 2018-2030년)
  • 시장 규모 : 투여 경로별(금액 기준, 2018-2030년)
  • 시장 규모 : 동물 종류별(금액 기준, 2018-2030년)
  • 시장 규모 : 유통 채널별(금액 기준, 2018-2030년)
  • 시장 규모 : 국가별(금액 기준, 2018-2030년)
    • 미국
    • 캐나다
  • 북미 시장 매력

제12장 유럽의 아티파메졸 시장 분석과 예측

제13장 아시아태평양의 아티파메졸 시장 분석과 예측

제14장 라틴아메리카의 아티파메졸 시장 분석과 예측

제15장 중동 및 아프리카의 아티파메졸 시장 분석과 예측

제16장 경쟁 상황

  • 시장 진출 기업 : 경쟁 매트릭스(기업 계층별·규모별)
  • 기업별 시장 점유율 분석/순위(2019년)
  • 기업 개요
    • Zoetis Services LLC
    • Merck & Co., Inc.(Merck Sharp & Dohme Corp)
    • Modern Veterinary Therapeutics
    • Orion Corporation
    • Jurox Pty Limited
    • Vetoquinol UK Limited
    • Chanelle Pharma Group
    • Forte Healthcare Ltd
    • Troy Laboratories Pty Ltd
KSM 20.08.31

List of Tables

  • Table 01: Global Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 02: Global Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 03: Global Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 04: Global Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 05: Global Atipamezole Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 06: North America Atipamezole Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 07: North America Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 08: North America Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 09: North America Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 10: North America Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 11: Europe Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 12: Europe Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 13: Europe Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 14: Europe Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 15: Europe Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 18: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 19: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 20: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 21: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 22: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 23: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 24: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 25: Latin America Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 26: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 27: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 28: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 29: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Animal Type, 2018-2030
  • Table 30: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Atipamezole Market Size (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Atipamezole Market Value Share, by Application, 2019
  • Figure 03: Global Atipamezole Market Value Share, by Route of Administration, 2019
  • Figure 04: Global Atipamezole Market Value Share, by Animal Type, 2019
  • Figure 05: Global Atipamezole Market Value Share, by Distribution Channel, 2019
  • Figure 06: Global Atipamezole Market Value Share, by Region, 2019
  • Figure 07: Global Atipamezole Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 08: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Anti-sedative, 2018-2030
  • Figure 09: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Antitoxic (Off-label use), 2018-2030
  • Figure 10: Global Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 11: Global Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 12: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Intramuscular, 2018-2030
  • Figure 13: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Intravenous, 2018-2030
  • Figure 14: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2018-2030
  • Figure 15: Global Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 16: Global Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 17: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Dogs, 2018-2030
  • Figure 18: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Cats, 2018-2030
  • Figure 19: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Animal Type, 2018-2030
  • Figure 20: Global Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 21: Global Atipamezole Market Value Share Analysis, by Distribution Channel 2019 and 2030
  • Figure 22: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Veterinary Hospitals, 2018-2030
  • Figure 23: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Retail Pharmacies, 2018-2030
  • Figure 24: Global Atipamezole Market Value (US$ Mn) and Y-o-Y Growth, by Online Pharmacies, 2018-2030
  • Figure 25: Global Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 26: Global Atipamezole Market Value Share Analysis, by Region, 2018 and 2030
  • Figure 27: Global Atipamezole Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 28: North America Atipamezole Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 29: North America Atipamezole Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 30: North America Atipamezole Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 31: North America Atipamezole Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 32: North America Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 33: North America Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 34: North America Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 35: North America Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 36: North America Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 37: North America Atipamezole Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 38: North America Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 39: Europe Atipamezole Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 40: Europe Atipamezole Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 41: Europe Atipamezole Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 42: Europe Atipamezole Market Value Share Application, by Application, 2019 and 2030
  • Figure 43: Europe Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 44: Europe Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 45: Europe Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 46: Europe Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 47: Europe Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 48: Europe Atipamezole Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 49: Europe Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 50: Asia Pacific Atipamezole Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 51: Asia Pacific Atipamezole Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 52: Asia Pacific Atipamezole Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 53: Asia Pacific Atipamezole Market Value Share Application, by Drug, 2019 and 2030
  • Figure 54: Asia Pacific Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 55: Asia Pacific Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 56: Asia Pacific Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 57: Asia Pacific Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 58: Asia Pacific Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 59: Asia Pacific Atipamezole Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 60: Asia Pacific Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 61: Latin America Atipamezole Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 62: Latin America Atipamezole Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 63: Latin America Atipamezole Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 64: Latin America Atipamezole Market Value Share Application, by Application, 2019 and 2030
  • Figure 65: Latin America Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 66: Latin America Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 67: Latin America Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 68: Latin America Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 69: Latin America Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 70: Latin America Atipamezole Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 71: Latin America Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 72: Middle East & Africa Atipamezole Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 73: Middle East & Africa Atipamezole Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 74: Middle East & Africa Atipamezole Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 75: Middle East & Africa Atipamezole Market Value Share Application, by Application, 2019 and 2030
  • Figure 76: Middle East & Africa Atipamezole Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 77: Middle East & Africa Atipamezole Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 78: Middle East & Africa Atipamezole Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 79: Middle East & Africa Atipamezole Market Value Share Analysis, by Animal Type, 2019 and 2030
  • Figure 80: Middle East & Africa Atipamezole Market Attractiveness Analysis, by Animal Type, 2020-2030
  • Figure 81: Middle East & Africa Atipamezole Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 82: Middle East & Africa Atipamezole Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 83: Global Atipamezole Market Analysis, by Top Company Ranking, 2020

Title:
Atipamezole Market (Application: Anti-sedative and Antitoxic [Off-label Use]; Route of Administration: Intramuscular, Intravenous, and Others; Animal Type: Dogs, Cats, and Others; and Distribution Channel: Veterinary Hospitals, Retail Pharmacies, and Online Pharmacies) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global atipamezole market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global atipamezole market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global atipamezole market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global atipamezole market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global atipamezole market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global atipamezole market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global atipamezole market.

The report delves into the competition landscape of the global atipamezole market. Key players operating in the global atipamezole market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global atipamezole market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth for product companies in the global atipamezole market?
  • What will be the Y-o-Y growth of the global atipamezole market between 2020 and 2030?
  • What is the influence of changing trends in technologies on the global atipamezole market?
  • Will North America continue to be the most profitable market for atipamezole?
  • Which factors are anticipated to hamper the growth of the global atipamezole market during the forecast period?
  • Which are the leading companies in the global atipamezole market?

Research Methodology

A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global atipamezole market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global atipamezole market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the atipamezole market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the atipamezole market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global atipamezole market with accuracy. The study also uses the top-down approach to assess the revenues of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global atipamezole more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Atipamezole Mark

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Application/Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Increase in number of pet ownership and pet adoption
      • 4.3.1.2. Rise in health care expenditure on animals
      • 4.3.1.3. Increase in awareness about veterinary care
    • 4.3.2. Restraints
      • 4.3.2.1. Side-effects of atipamezole
      • 4.3.2.2. Stringent government regulations
    • 4.3.3. Opportunities
      • 4.3.3.1. Research & Development
      • 4.3.3.2. Expansion in Emerging Market
  • 4.4. Global Atipamezole Market Analysis and Forecast, 2018-2030

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. Number of Animals, by Country/Sub-region
  • 5.3. Overview of Veterinary Care

6. Global Atipamezole Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Atipamezole Market Value Forecast, by Application, 2018-2030
    • 6.3.1. Anti-sedative
    • 6.3.2. Antitoxic (Off-label use)
  • 6.4. Global Atipamezole Market Attractiveness, by Application

7. Global Atipamezole Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 7.3.1. Intramuscular
    • 7.3.2. Intravenous
    • 7.3.3. Others
  • 7.4. Global Atipamezole Market Attractiveness, by Route of Administration

8. Global Atipamezole Market Analysis and Forecast, by Animal Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 8.3.1. Dogs
    • 8.3.2. Cats
    • 8.3.3. Others
  • 8.4. Global Atipamezole Market Attractiveness, by Animal Type

9. Global Atipamezole Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Global Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Global Atipamezole Market Attractiveness, by Distribution Channel

10. Global Atipamezole Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Global Atipamezole Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Global Atipamezole Market Attractiveness, by Country/Region

11. North America Atipamezole Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. North America Atipamezole Market Value Forecast, by Application, 2018-2030
    • 11.2.1. Anti-sedative
    • 11.2.2. Antitoxic (Off-label use)
  • 11.3. North America Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 11.3.1. Intramuscular
    • 11.3.2. Intravenous
    • 11.3.3. Others
  • 11.4. North America Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 11.4.1. Dogs
    • 11.4.2. Cats
    • 11.4.3. Others
  • 11.5. North America Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 11.5.1. Veterinary Hospitals
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. North America Atipamezole Market Value Forecast, by Country, 2018-2030
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. North America Atipamezole Market Attractiveness Analysis
    • 11.7.1. By Application
    • 11.7.2. By Route of Administration
    • 11.7.3. By Animal Type
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Atipamezole Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Europe Atipamezole Market Value Forecast, by Application, 2018-2030
    • 12.2.1. Anti-sedative
    • 12.2.2. Antitoxic (Off-label use)
  • 12.3. Europe Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 12.3.1. Intramuscular
    • 12.3.2. Intravenous
    • 12.3.3. Others
  • 12.4. Europe Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 12.4.1. Dogs
    • 12.4.2. Cats
    • 12.4.3. Others
  • 12.5. Europe Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 12.5.1. Veterinary Hospitals
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Europe Atipamezole Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Europe Atipamezole Market Attractiveness Analysis
    • 12.7.1. By Application
    • 12.7.2. By Route of Administration
    • 12.7.3. By Animal Type
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Atipamezole Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Asia Pacific Atipamezole Market Value Forecast, by Application, 2018-2030
    • 13.2.1. Anti-sedative
    • 13.2.2. Antitoxic (Off-label use)
  • 13.3. Asia Pacific Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 13.3.1. Intramuscular
    • 13.3.2. Intravenous
    • 13.3.3. Others
  • 13.4. Asia Pacific Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 13.4.1. Dogs
    • 13.4.2. Cats
    • 13.4.3. Others
  • 13.5. Asia Pacific Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 13.5.1. Veterinary Hospitals
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Asia Pacific Atipamezole Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Asia Pacific Atipamezole Market Attractiveness Analysis
    • 13.7.1. By Application
    • 13.7.2. By Route of Administration
    • 13.7.3. By Animal Type
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Atipamezole Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Latin America Atipamezole Market Value Forecast, by Application, 2018-2030
    • 14.2.1. Anti-sedative
    • 14.2.2. Antitoxic (Off-label use)
  • 14.3. Latin America Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 14.3.1. Intramuscular
    • 14.3.2. Intravenous
    • 14.3.3. Others
  • 14.4. Latin America Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 14.4.1. Dogs
    • 14.4.2. Cats
    • 14.4.3. Others
  • 14.5. Latin America Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 14.5.1. Veterinary Hospitals
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Latin America Atipamezole Market Value Forecast, by Country/Sub-region, 2018-2030
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Latin America Atipamezole Market Attractiveness Analysis
    • 14.7.1. By Application
    • 14.7.2. By Route of Administration
    • 14.7.3. By Animal Type
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Atipamezole Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Middle East & Africa Atipamezole Market Value Forecast, by Application, 2018-2030
    • 15.2.1. Anti-sedative
    • 15.2.2. Antitoxic (Off-label use)
  • 15.3. Middle East & Africa Atipamezole Market Value Forecast, by Route of Administration, 2018-2030
    • 15.3.1. Intramuscular
    • 15.3.2. Intravenous
    • 15.3.3. Others
  • 15.4. Middle East & Africa Atipamezole Market Value Forecast, by Animal Type, 2018-2030
    • 15.4.1. Dogs
    • 15.4.2. Cats
    • 15.4.3. Others
  • 15.5. Middle East & Africa Atipamezole Market Value Forecast, by Distribution Channel, 2018-2030
    • 15.5.1. Veterinary Hospitals
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Middle East & Africa Atipamezole Market Value Forecast, by Country/Sub-region, 2018-2030
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Middle East & Africa Atipamezole Market Attractiveness Analysis
    • 15.7.1. By Application
    • 15.7.2. By Route of Administration
    • 15.7.3. By Animal Type
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 16.2. Market Share Analysis/Ranking by Company (2019)
  • 16.3. Company Profiles
    • 16.3.1. Zoetis Services LLC
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Company Financials
      • 16.3.1.3. Growth Strategies
      • 16.3.1.4. SWOT Analysis
    • 16.3.2. Merck & Co., Inc. (Merck Sharp & Dohme Corp)
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Company Financials
      • 16.3.2.3. Growth Strategies
      • 16.3.2.4. SWOT Analysis
    • 16.3.3. Modern Veterinary Therapeutics
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Growth Strategies
      • 16.3.3.3. SWOT Analysis
    • 16.3.4. Orion Corporation
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Company Financials
      • 16.3.4.3. Growth Strategies
      • 16.3.4.4. SWOT Analysis
    • 16.3.5. Jurox Pty Limited
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Growth Strategies
      • 16.3.5.3. SWOT Analysis
    • 16.3.6. Vetoquinol UK Limited
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Company Financials
      • 16.3.6.3. Growth Strategies
      • 16.3.6.4. SWOT Analysis
    • 16.3.7. Chanelle Pharma Group
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Growth Strategies
      • 16.3.7.3. SWOT Analysis
    • 16.3.8. Forte Healthcare Ltd
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Growth Strategies
      • 16.3.8.3. SWOT Analysis
    • 16.3.9. Troy Laboratories Pty Ltd
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Growth Strategies
      • 16.3.9.3. SWOT Analysis
Back to Top
전화 문의
F A Q